Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC reject Rectogesic

The Scottish Medicines Consortium (SMC) has rejected Glyceryl Trinitrate 0.4% Ointment (Rectogesic)® for use on the NHS in Scotland for a second time.

This latest advice is based upon a resubmission of data after the SMC had rejected the product last year as reported here.

The SMC accept that this product is associated with a very small decrease in pain the economic case has not been demonstrated. The economic case is based on a comparison to Anacal, Anusol and Xyloproct all of which are licensed for the relief of pain associated with anal fissures. Rectogesic is about 10 times more expensive than these products.

Action: First line treatment of anal fissures should be based on lifestyle advice about diet and bowel habit. Prescriptions for products containing topical steroids or anaesthetics may be appropriate for management of pain and inflammation.

Share 'SMC reject Rectogesic' on Email Share 'SMC reject Rectogesic' on Delicious Share 'SMC reject Rectogesic' on Digg Share 'SMC reject Rectogesic' on Facebook Share 'SMC reject Rectogesic' on Google+ Share 'SMC reject Rectogesic' on reddit Share 'SMC reject Rectogesic' on StumbleUpon Share 'SMC reject Rectogesic' on Twitter

atomic-wealth

No Comments to “SMC reject Rectogesic”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,521 spam comments.

atomic-wealth
fond-illness
summer